Indivior on the back foot as Federal court rejects Suboxone appeal
https://www.proactiveinvestors.co.uk/companies/news/213965/indivior-on-the-back-foot-as-federal-court-rejects-suboxone-appeal-213965.html
Indivior on the back foot as Federal court rejects Suboxone appeal
07:55 05 Feb 2019
Indivior PLC (LON:INDV) has suffered a major setback in attempts to defend its best-selling opioid addiction drug Suboxone from generic competition. A US Federal Court of Appeal (CAFC) rejected Indiviors request for another hearing on whether its patents were infringed by a low-cost alternative developed by Dr Reddy.
A district court in Delaware had previously given the all-clear to the generic version. The decision by the CAFC effectively ratifies that and clears the way for Dr Reddy to sell its rival in the US.
Indivior has applied for an emergency injunction to stop the Federal Courts mandate, which comes into force on February 11. Without that, Indivior expects both Dr Reddy and Alvogen, another generic rival, would start to market their products on that date.
(snip)